Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
9
self-reported 2–10 band
Founded
2020
6 years
Registry matches
1
ABR
Office countries
1
1 address
Funding rounds
7
Series B · Nov 2025 · US$ 22.4M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 possible registrationThese are name matches on ABR. 1 registration share this brand's name; which one you contract with is a question for the register.
ENA RESPIRATORY PTY LTD
ABN23641651041
Legal entities
Show as table · ENA Respiratory: 1 registry entity
| ENA RESPIRATORY PTY LTD | ABN 23641651041 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
ENA Respiratory is a clinical-stage pharmaceutical company developing INNA-051, an intranasal innate immune modulator for the prevention of complications resulting from respiratory viral infections in at-risk populations, including older adults, those with co-morbidities (COPD, asthma, diabetes, and cardiovascular disease) and individuals with occupational risk. The ENA team has a long history of successful drug development in respiratory diseases and seeks to leverage this expertise to meet the considerable unmet need that still exists for these vulnerable populations.
ENA Respiratory has partnered with the COPD Foundation to enable and optimize patient-centered clinical development of INNA-051 in COPD. In 2022, it joined BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation and BARDA designed to accelerate development of potential solutions for future pandemics. In 2023, the company was awarded a $8.18 million contract from the U.S. Department of Defense to support the continued development of INNA-051.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU31 Queen Street; Melbourne, Victoria 3000Primary
Grid intelligence Members
Funding
Last round · 22 November 2025US$ 22.4MSeries B
Rounds7
Round typeSeries B · venture round
Amount (USD)22,400,000
Stage rank4
Investors named0
Since last round2 mo
Funding
Show as table · 7 funding rounds
| Rounds | 7 |
|---|---|
| Axis | 2020 to 2026 |
| Series B · 22 Nov 2025 | US$ 22.4M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under ENA Respiratory?
One New South Wales entity on the ABR. ENA RESPIRATORY PTY LTD (ABN 23 641 651 041), medium confidence.
How many people work at ENA Respiratory?
The record holds 9 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does ENA Respiratory have offices?
One address on record, Australia only. Primary: 31 Queen Street, Melbourne, Victoria 3000.
Has ENA Respiratory raised funding?
Seven rounds. Latest 22 November 2025: Series B, US$22,400,000.
Which companies are listed alongside ENA Respiratory?
Eight peer profiles on record: Nutromics and Certa Therapeutics.